AI Dreams and Consumer Realities: What the Market's Misfits Tell Us About 2026Global Report·1 day ago, 04:13 AMKALA+2.00%PLAG+1.08%
The Biotech Survival Charade: Stop Buying the "AI Pivot" HypeGlobal Report·Jul 26 at 04:14 AMINM0.00%ONCY-5.11%
The Market's Leftover Drawer: Who's Actually Building and Who's Sleepwalking?Global Report·Jul 25 at 04:18 AMVCIG+12.17%ALLY-2.63%
Cohu and VIAVI Signal Stronger AI Hardware Demand as Tech Supply Chain Beats EstimatesGlobal Report·Jul 25 at 04:13 AMVIAV-8.18%COHU-7.37%
The 2026 Biotech Divide: When Generative Biology Meets the FDA WallGlobal Report·Jul 24 at 04:13 AMINM0.00%TXG-1.55%
Unbundling the Value Chain: Business Models from Digital Infrastructure to Physical ScaleGlobal Report·Jul 14 at 06:47 AMCHRS-2.08%REI+7.08%
Capital Reallocation and Physical Constraints: The Barbell Market of 2026Global Report·Jul 8 at 10:32 PMKALA+2.00%GENK+0.25%
Pre-market hot trades in US stocks: Kala Bio up 9.83% in pre-market, active funds but no positive newsPrice Alert·Jul 1 at 05:37 AMKALA+2.00%
U.S. stock market midday update: KALA BIO rises 20.21%, gene-editing ophthalmic therapy in demandPrice Alert·Jun 18 at 11:27 AMKALA+2.00%
Rebundling the Tech Stack: How Hardware and AI Reshape the Value ChainGlobal Report·Jun 18 at 07:46 AMLUMN+0.81%FIVN+0.17%
KALA BIO, Inc. 1Q 2026: Net loss $(1.6M), Diluted EPS $(0.14) — 10-Q SummaryTradingView·May 15 at 02:41 PMKALA+2.00%LABU-4.04%
U.S. stock night market volatility: Kala Bio fell 10.58% in after-hours trading, with no significant news but showing volatility. What is causing such market sentiment?Price Alert·May 13 at 12:11 AMKALA+2.00%
KALA BIO Stock Scheduled to Reverse Split on Monday, May 11th (NASDAQ:KALA)Market Beat·May 7 at 06:01 PMKALA+2.00%ARKG-0.85%
KALA BIO shares are trading lower after the company announced a 1-for-50 reverse stock split.benzinga_article·May 7 at 08:24 AMKALA+2.00%LABU-4.04%
